Tetradecyl Nicotinate - CAS 273203-62-6
Catalog: |
BB019527 |
Product Name: |
Tetradecyl Nicotinate |
CAS: |
273203-62-6 |
Synonyms: |
3-pyridinecarboxylic acid tetradecyl ester; tetradecyl pyridine-3-carboxylate |
IUPAC Name: | tetradecyl pyridine-3-carboxylate |
Description: | Tetradecyl Nicotinate can be combined with other drugs in the treatment of dermatological conditions. |
Molecular Weight: | 319.48 |
Molecular Formula: | C20H33NO2 |
Canonical SMILES: | CCCCCCCCCCCCCCOC(=O)C1=CN=CC=C1 |
InChI: | InChI=1S/C20H33NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-23-20(22)19-15-14-16-21-18-19/h14-16,18H,2-13,17H2,1H3 |
InChI Key: | TVGLGJWCZSCAEM-UHFFFAOYSA-N |
Boiling Point: | 411.7 °C at 760 mmHg |
Flash Point: | 202.8°C |
Density: | 0.953 g/cm3 |
Solubility: | water, 0.009464 mg/L @ 25 °C (est) |
Appearance: | Solid |
LogP: | 5.93950 |
Refractive Index: | 1.486 |
Publication Number | Title | Priority Date |
CN-111956561-A | Lip cosmetic and preparation method thereof | 20200923 |
US-10959933-B1 | Low pH skin care composition and methods of using the same | 20200601 |
CA-3112116-A1 | Low ph skin care composition and methods of using the same | 20200601 |
US-2021315434-A1 | Cleaning article with preferential rheological solid composition | 20200410 |
US-2021315435-A1 | Cleaning implement with a rheological solid composition | 20200410 |
PMID | Publication Date | Title | Journal |
21772756 | 20110401 | Design and development of a stable polyherbal formulation based on the results of compatibility studies | Pharmacognosy research |
21655214 | 20110101 | Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation | PloS one |
21826208 | 20110101 | Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma | PloS one |
17927576 | 20071101 | Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage | Experimental dermatology |
18058313 | 20071101 | Formulation compatibility of myristyl nicotinate with drugs used to treat dermatological conditions involving an impaired skin barrier | Drug development and industrial pharmacy |
Complexity: | 281 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 319.251129295 |
Formal Charge: | 0 |
Heavy Atom Count: | 23 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 319.251129295 |
Rotatable Bond Count: | 15 |
Topological Polar Surface Area: | 39.2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 7.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS